chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Positive airway pressure therapy, Pulmonary mass, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: Pfizer Dose 1 2/8/21 (EN6201) Pfizer Dose 2 3/1/21 (EN6203) COVID Positive 1/4/22  1/4/22: Patient is an 87-year-old male with past medical history significant for type 2 diabetes, CKD, CAD s/p stent placement, hypertension, B12 deficiency, history of unprovoked PE in 2018 currently anticoagulated on Eliquis, recent COVID-19 infection, melanoma with metastatic disease to lungs.  The patient presents to the ED today via EMS from a facility with worsening shortness of breath.  Of note, the patient was admitted to the Hospital for 3 weeks due to COVID-19 pneumonia, he was discharged to a facility 1/3/2022 on 8 L of oxygen via nasal cannula.  The patient's HPI is difficult to obtain due to his significant hypoxia and fatigue. The patient is not able to answer questions appropriately during examination.  Of note, the patient follows with Dr. for the management of his metastatic melanoma.  The patient had a CT of his chest completed on 11/30/2021 and reviewed slight enlargement of the pulmonary nodule in the right middle lobe.  He was previously being treated with keytruda; however, it has been on hold for 2 months due to worsening performance while on keytruda.   Upon arrival to the ED patient's temperature is 99.3°, heart rate 88, respirations 39, pulse ox 91% on 15 L high-flow oxygen, blood pressure 117/58.  The patient was subsequently placed on BiPAP at 50% FiO2 to maintain O2 saturations greater than 90%.  Patient's laboratory findings are significant for sodium 130, chloride 93, a gap 18, glucose 205, BUN 38, creatinine 1.68, AST 64, WBC 12.71, hemoglobin 11.5, hematocrit 36.1.  The patient received 6 mg IV Decadron, DuoNeb x1, Levaquin 750 mg IV, 2 L IV normal saline in ED.  1/6/22: Discontinue routine blood checks  Discontinue glucometer and insulin  Continue with comfort measures  Follow-up with care coordination and hospice team about DC to skilled on hospice Other medications discontinued.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Pfizer Dose 1 2/8/21 (EN6201) Pfizer Dose 2 3/1/21 (EN6203) COVID Positive 1/4/22  1/4/22: Patient is an 87-year-old male with past medical history significant for type 2 diabetes, CKD, CAD s/p stent placement, hypertension, B12 deficiency, history of unprovoked PE in 2018 currently anticoagulated on Eliquis, recent COVID-19 infection, melanoma with metastatic disease to lungs.  The patient presents to the ED today via EMS from a facility with worsening shortness of breath.  Of note, the patient was admitted to the Hospital for 3 weeks due to COVID-19 pneumonia, he was discharged to a facility 1/3/2022 on 8 L of oxygen via nasal cannula.  The patient's HPI is difficult to obtain due to his significant hypoxia and fatigue. The patient is not able to answer questions appropriately during examination.  Of note, the patient follows with Dr. for the management of his metastatic melanoma.  The patient had a CT of his chest completed on 11/30/2021 and reviewed slight enlargement of the pulmonary nodule in the right middle lobe.  He was previously being treated with keytruda; however, it has been on hold for 2 months due to worsening performance while on keytruda.   Upon arrival to the ED patient's temperature is 99.3°, heart rate 88, respirations 39, pulse ox 91% on 15 L high-flow oxygen, blood pressure 117/58.  The patient was subsequently placed on BiPAP at 50% FiO2 to maintain O2 saturations greater than 90%.  Patient's laboratory findings are significant for sodium 130, chloride 93, a gap 18, glucose 205, BUN 38, creatinine 1.68, AST 64, WBC 12.71, hemoglobin 11.5, hematocrit 36.1.  The patient received 6 mg IV Decadron, DuoNeb x1, Levaquin 750 mg IV, 2 L IV normal saline in ED.  1/6/22: Discontinue routine blood checks  Discontinue glucometer and insulin  Continue with comfort measures  Follow-up with care coordination and hospice team about DC to skilled on hospice Other medications discontinued.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Assisted living patient at Health center who tested positive for Covid-19 on 12/20/2021.  At the time patient was asymptomatic.  Patient expired at same facility on 01/22/2022.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. no follow-up needed. no adverse outcome
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aspartate aminotransferase increased, Asthenia, Atelectasis, Chemotherapy, Chest X-ray abnormal
Clinical narrative: Hospitalized 1/3/22 - 1/8/22 and 1/14/22 - 1/26/22. During first admission, received remdesivir and discharged on O2. On second admission, presented with increased generalized weakness, fever, hypoxemia. Required continuous BiPAP on max settings. Chest tube placed and intubation discussed but family opted to transition to comfort care. Pt expired shortly after BiPAP was removed.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest tube insertion, Death, Endotracheal intubation, Haematocrit decreased, Hypoxia
Clinical narrative: Hospitalized 1/3/22 - 1/8/22 and 1/14/22 - 1/26/22. During first admission, received remdesivir and discharged on O2. On second admission, presented with increased generalized weakness, fever, hypoxemia. Required continuous BiPAP on max settings. Chest tube placed and intubation discussed but family opted to transition to comfort care. Pt expired shortly after BiPAP was removed.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lung infiltration, Platelet count decreased, Positive airway pressure therapy, Pulmonary oedema, Pyrexia
Clinical narrative: Hospitalized 1/3/22 - 1/8/22 and 1/14/22 - 1/26/22. During first admission, received remdesivir and discharged on O2. On second admission, presented with increased generalized weakness, fever, hypoxemia. Required continuous BiPAP on max settings. Chest tube placed and intubation discussed but family opted to transition to comfort care. Pt expired shortly after BiPAP was removed.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin I increased
Clinical narrative: Hospitalized 1/3/22 - 1/8/22 and 1/14/22 - 1/26/22. During first admission, received remdesivir and discharged on O2. On second admission, presented with increased generalized weakness, fever, hypoxemia. Required continuous BiPAP on max settings. Chest tube placed and intubation discussed but family opted to transition to comfort care. Pt expired shortly after BiPAP was removed.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, Bile duct stenosis, Blood alkaline phosphatase increased, COVID-19
Clinical narrative: J&J Dose 3/15/21 Covid Positive 1/21/22  1/21/22: An 88-year-old lady presented to the emergency room with history of increasing weakness as noted by daughter.  The patient is a poor historian.  Her daughter said that she has been having difficulty ambulating by herself and had to be helped to get out of the car by the nursing staff and brought to the emergency room by wheelchair.  The patient was just recently treated for UTI.  She denies chest pain. Reports fatigue. She denies fever.  1/25/22: Patient is an 88-year-old female who presented to the emergency department due to worsening weakness, admitted for acute renal failure, UTI, and metabolic encephalopathy.  Patient tested positive for COVID-19 however with no concern of pneumonia, she was saturating well on room air throughout hospitalization with no respiratory distress.  Started on levofloxacin renally dosed which covered for UTI.  She had significantly elevated liver enzymes and alkaline phosphatase for which she underwent HIDA scan which came back negative, she underwent MRCP that showed multiple areas of stenosis in common bile duct dilation, GI consulted who recommended close follow-up in 3 weeks as an outpatient basis.  Kidney function normalized, hyperkalemia resolved, patient was tolerating oral intake and was stable for discharge.  PT/OT evaluation and recommendations were to discharge to skilled nursing facility however family want to take the patient home.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Hepatic enzyme increased, Hepatobiliary scan, Hyperkalaemia
Clinical narrative: J&J Dose 3/15/21 Covid Positive 1/21/22  1/21/22: An 88-year-old lady presented to the emergency room with history of increasing weakness as noted by daughter.  The patient is a poor historian.  Her daughter said that she has been having difficulty ambulating by herself and had to be helped to get out of the car by the nursing staff and brought to the emergency room by wheelchair.  The patient was just recently treated for UTI.  She denies chest pain. Reports fatigue. She denies fever.  1/25/22: Patient is an 88-year-old female who presented to the emergency department due to worsening weakness, admitted for acute renal failure, UTI, and metabolic encephalopathy.  Patient tested positive for COVID-19 however with no concern of pneumonia, she was saturating well on room air throughout hospitalization with no respiratory distress.  Started on levofloxacin renally dosed which covered for UTI.  She had significantly elevated liver enzymes and alkaline phosphatase for which she underwent HIDA scan which came back negative, she underwent MRCP that showed multiple areas of stenosis in common bile duct dilation, GI consulted who recommended close follow-up in 3 weeks as an outpatient basis.  Kidney function normalized, hyperkalemia resolved, patient was tolerating oral intake and was stable for discharge.  PT/OT evaluation and recommendations were to discharge to skilled nursing facility however family want to take the patient home.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance cholangiopancreatography, Metabolic encephalopathy, Renal impairment, SARS-CoV-2 test positive, Urinary tract infection
Clinical narrative: J&J Dose 3/15/21 Covid Positive 1/21/22  1/21/22: An 88-year-old lady presented to the emergency room with history of increasing weakness as noted by daughter.  The patient is a poor historian.  Her daughter said that she has been having difficulty ambulating by herself and had to be helped to get out of the car by the nursing staff and brought to the emergency room by wheelchair.  The patient was just recently treated for UTI.  She denies chest pain. Reports fatigue. She denies fever.  1/25/22: Patient is an 88-year-old female who presented to the emergency department due to worsening weakness, admitted for acute renal failure, UTI, and metabolic encephalopathy.  Patient tested positive for COVID-19 however with no concern of pneumonia, she was saturating well on room air throughout hospitalization with no respiratory distress.  Started on levofloxacin renally dosed which covered for UTI.  She had significantly elevated liver enzymes and alkaline phosphatase for which she underwent HIDA scan which came back negative, she underwent MRCP that showed multiple areas of stenosis in common bile duct dilation, GI consulted who recommended close follow-up in 3 weeks as an outpatient basis.  Kidney function normalized, hyperkalemia resolved, patient was tolerating oral intake and was stable for discharge.  PT/OT evaluation and recommendations were to discharge to skilled nursing facility however family want to take the patient home.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Wheelchair user
Clinical narrative: J&J Dose 3/15/21 Covid Positive 1/21/22  1/21/22: An 88-year-old lady presented to the emergency room with history of increasing weakness as noted by daughter.  The patient is a poor historian.  Her daughter said that she has been having difficulty ambulating by herself and had to be helped to get out of the car by the nursing staff and brought to the emergency room by wheelchair.  The patient was just recently treated for UTI.  She denies chest pain. Reports fatigue. She denies fever.  1/25/22: Patient is an 88-year-old female who presented to the emergency department due to worsening weakness, admitted for acute renal failure, UTI, and metabolic encephalopathy.  Patient tested positive for COVID-19 however with no concern of pneumonia, she was saturating well on room air throughout hospitalization with no respiratory distress.  Started on levofloxacin renally dosed which covered for UTI.  She had significantly elevated liver enzymes and alkaline phosphatase for which she underwent HIDA scan which came back negative, she underwent MRCP that showed multiple areas of stenosis in common bile duct dilation, GI consulted who recommended close follow-up in 3 weeks as an outpatient basis.  Kidney function normalized, hyperkalemia resolved, patient was tolerating oral intake and was stable for discharge.  PT/OT evaluation and recommendations were to discharge to skilled nursing facility however family want to take the patient home.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: After I tested positive I had a fever of 102, coughing.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives on face within 5 minutes of getting vaccine. 2 hours later hives on wrist
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Ageusia, Anosmia, Anticoagulant therapy, Arteriogram coronary abnormal
Clinical narrative: Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) Pfizer Dose 3 8/20/21 (EW0177) COVID Positive 1/30/22  1/30/22: Patient is a 75-year-old male who is immunosuppressed status post right renal transplant (2020) secondary to polycystic kidney disease who presented to ED with complaints of shortness of breath.  Patient has been fully vaccinated against COVID-19 and received his booster. He also tested positive for COVID last October.  Patient recently traveled with his wife who has since tested positive for COVID.  Patient began developing sinus congestion, low-grade fevers and loss of taste and smell. He was tested for COVID on Monday of last week with positive results.  He has been monitoring his pulse ox at home for the past several days and it has been dropping below 90%. He began experiencing shortness of breath yesterday with worsening symptoms today. He denies chest pain. No nausea, vomiting or diarrhea.  He has a past medical history of hypertension, GERD, hyperlipidemia, obstructive sleep apnea and prediabetes.  Patient follows with medical facility for renal transplant and is an on mycophenolate mofetil, prednisone and tacrolimus.  Patient did receive monoclonal antibody infusion 2 days ago.   On arrival to ED patient was hypoxic on room air at 87%, supplemental oxygen was applied any is currently on 4 L saturating around 94%.  Laboratory findings were significant for CKD stage 4 BUN 28 and creatinine 1.34. Hypomagnesemia 1.5.  Given 1 g Mag rider in ED.  D-dimer 0.61.  C reactive 3.60.  Chest x-ray shows new severe airspace disease in both lungs consistent with pneumonia. Unchanged right lower lobe nodule most consistent with granuloma.  EKG normal sinus rhythm, rate 80, QTC 408.  Azithromycin and Rocephin initiated in ED, Decadron 6 mg IV given.  2/5/22: 75-year-old gentleman presented to the emergency room with history of chest pain.  The patient was discharged from the hospital following management focal COVID just 3 days ago prior to admission.  Patient was noted to have troponin trending up, and hence treated for NSTEMI.  Patient to start on heparin drip.  He eventually underwent coronary angiogram with intervention and DES stent.  The patient's symptoms have resolved.  The patient has developed right groin hematoma on the site of catheterization, and as per my review, the hematoma is resolving and lower extremity pulses are within normal range.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Blood creatinine increased, Blood magnesium normal, Blood urea increased, C-reactive protein increased, COVID-19
Clinical narrative: Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) Pfizer Dose 3 8/20/21 (EW0177) COVID Positive 1/30/22  1/30/22: Patient is a 75-year-old male who is immunosuppressed status post right renal transplant (2020) secondary to polycystic kidney disease who presented to ED with complaints of shortness of breath.  Patient has been fully vaccinated against COVID-19 and received his booster. He also tested positive for COVID last October.  Patient recently traveled with his wife who has since tested positive for COVID.  Patient began developing sinus congestion, low-grade fevers and loss of taste and smell. He was tested for COVID on Monday of last week with positive results.  He has been monitoring his pulse ox at home for the past several days and it has been dropping below 90%. He began experiencing shortness of breath yesterday with worsening symptoms today. He denies chest pain. No nausea, vomiting or diarrhea.  He has a past medical history of hypertension, GERD, hyperlipidemia, obstructive sleep apnea and prediabetes.  Patient follows with medical facility for renal transplant and is an on mycophenolate mofetil, prednisone and tacrolimus.  Patient did receive monoclonal antibody infusion 2 days ago.   On arrival to ED patient was hypoxic on room air at 87%, supplemental oxygen was applied any is currently on 4 L saturating around 94%.  Laboratory findings were significant for CKD stage 4 BUN 28 and creatinine 1.34. Hypomagnesemia 1.5.  Given 1 g Mag rider in ED.  D-dimer 0.61.  C reactive 3.60.  Chest x-ray shows new severe airspace disease in both lungs consistent with pneumonia. Unchanged right lower lobe nodule most consistent with granuloma.  EKG normal sinus rhythm, rate 80, QTC 408.  Azithromycin and Rocephin initiated in ED, Decadron 6 mg IV given.  2/5/22: 75-year-old gentleman presented to the emergency room with history of chest pain.  The patient was discharged from the hospital following management focal COVID just 3 days ago prior to admission.  Patient was noted to have troponin trending up, and hence treated for NSTEMI.  Patient to start on heparin drip.  He eventually underwent coronary angiogram with intervention and DES stent.  The patient's symptoms have resolved.  The patient has developed right groin hematoma on the site of catheterization, and as per my review, the hematoma is resolving and lower extremity pulses are within normal range.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Catheterisation cardiac abnormal, Chest X-ray abnormal, Chest pain, Chronic kidney disease, Coronary arterial stent insertion
Clinical narrative: Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) Pfizer Dose 3 8/20/21 (EW0177) COVID Positive 1/30/22  1/30/22: Patient is a 75-year-old male who is immunosuppressed status post right renal transplant (2020) secondary to polycystic kidney disease who presented to ED with complaints of shortness of breath.  Patient has been fully vaccinated against COVID-19 and received his booster. He also tested positive for COVID last October.  Patient recently traveled with his wife who has since tested positive for COVID.  Patient began developing sinus congestion, low-grade fevers and loss of taste and smell. He was tested for COVID on Monday of last week with positive results.  He has been monitoring his pulse ox at home for the past several days and it has been dropping below 90%. He began experiencing shortness of breath yesterday with worsening symptoms today. He denies chest pain. No nausea, vomiting or diarrhea.  He has a past medical history of hypertension, GERD, hyperlipidemia, obstructive sleep apnea and prediabetes.  Patient follows with medical facility for renal transplant and is an on mycophenolate mofetil, prednisone and tacrolimus.  Patient did receive monoclonal antibody infusion 2 days ago.   On arrival to ED patient was hypoxic on room air at 87%, supplemental oxygen was applied any is currently on 4 L saturating around 94%.  Laboratory findings were significant for CKD stage 4 BUN 28 and creatinine 1.34. Hypomagnesemia 1.5.  Given 1 g Mag rider in ED.  D-dimer 0.61.  C reactive 3.60.  Chest x-ray shows new severe airspace disease in both lungs consistent with pneumonia. Unchanged right lower lobe nodule most consistent with granuloma.  EKG normal sinus rhythm, rate 80, QTC 408.  Azithromycin and Rocephin initiated in ED, Decadron 6 mg IV given.  2/5/22: 75-year-old gentleman presented to the emergency room with history of chest pain.  The patient was discharged from the hospital following management focal COVID just 3 days ago prior to admission.  Patient was noted to have troponin trending up, and hence treated for NSTEMI.  Patient to start on heparin drip.  He eventually underwent coronary angiogram with intervention and DES stent.  The patient's symptoms have resolved.  The patient has developed right groin hematoma on the site of catheterization, and as per my review, the hematoma is resolving and lower extremity pulses are within normal range.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram QT interval, Electrocardiogram normal, Exposure to SARS-CoV-2, Fibrin D dimer
Clinical narrative: Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) Pfizer Dose 3 8/20/21 (EW0177) COVID Positive 1/30/22  1/30/22: Patient is a 75-year-old male who is immunosuppressed status post right renal transplant (2020) secondary to polycystic kidney disease who presented to ED with complaints of shortness of breath.  Patient has been fully vaccinated against COVID-19 and received his booster. He also tested positive for COVID last October.  Patient recently traveled with his wife who has since tested positive for COVID.  Patient began developing sinus congestion, low-grade fevers and loss of taste and smell. He was tested for COVID on Monday of last week with positive results.  He has been monitoring his pulse ox at home for the past several days and it has been dropping below 90%. He began experiencing shortness of breath yesterday with worsening symptoms today. He denies chest pain. No nausea, vomiting or diarrhea.  He has a past medical history of hypertension, GERD, hyperlipidemia, obstructive sleep apnea and prediabetes.  Patient follows with medical facility for renal transplant and is an on mycophenolate mofetil, prednisone and tacrolimus.  Patient did receive monoclonal antibody infusion 2 days ago.   On arrival to ED patient was hypoxic on room air at 87%, supplemental oxygen was applied any is currently on 4 L saturating around 94%.  Laboratory findings were significant for CKD stage 4 BUN 28 and creatinine 1.34. Hypomagnesemia 1.5.  Given 1 g Mag rider in ED.  D-dimer 0.61.  C reactive 3.60.  Chest x-ray shows new severe airspace disease in both lungs consistent with pneumonia. Unchanged right lower lobe nodule most consistent with granuloma.  EKG normal sinus rhythm, rate 80, QTC 408.  Azithromycin and Rocephin initiated in ED, Decadron 6 mg IV given.  2/5/22: 75-year-old gentleman presented to the emergency room with history of chest pain.  The patient was discharged from the hospital following management focal COVID just 3 days ago prior to admission.  Patient was noted to have troponin trending up, and hence treated for NSTEMI.  Patient to start on heparin drip.  He eventually underwent coronary angiogram with intervention and DES stent.  The patient's symptoms have resolved.  The patient has developed right groin hematoma on the site of catheterization, and as per my review, the hematoma is resolving and lower extremity pulses are within normal range.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Granuloma, Haematoma, Hypomagnesaemia, Hypoxia, Interventional procedure
Clinical narrative: Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) Pfizer Dose 3 8/20/21 (EW0177) COVID Positive 1/30/22  1/30/22: Patient is a 75-year-old male who is immunosuppressed status post right renal transplant (2020) secondary to polycystic kidney disease who presented to ED with complaints of shortness of breath.  Patient has been fully vaccinated against COVID-19 and received his booster. He also tested positive for COVID last October.  Patient recently traveled with his wife who has since tested positive for COVID.  Patient began developing sinus congestion, low-grade fevers and loss of taste and smell. He was tested for COVID on Monday of last week with positive results.  He has been monitoring his pulse ox at home for the past several days and it has been dropping below 90%. He began experiencing shortness of breath yesterday with worsening symptoms today. He denies chest pain. No nausea, vomiting or diarrhea.  He has a past medical history of hypertension, GERD, hyperlipidemia, obstructive sleep apnea and prediabetes.  Patient follows with medical facility for renal transplant and is an on mycophenolate mofetil, prednisone and tacrolimus.  Patient did receive monoclonal antibody infusion 2 days ago.   On arrival to ED patient was hypoxic on room air at 87%, supplemental oxygen was applied any is currently on 4 L saturating around 94%.  Laboratory findings were significant for CKD stage 4 BUN 28 and creatinine 1.34. Hypomagnesemia 1.5.  Given 1 g Mag rider in ED.  D-dimer 0.61.  C reactive 3.60.  Chest x-ray shows new severe airspace disease in both lungs consistent with pneumonia. Unchanged right lower lobe nodule most consistent with granuloma.  EKG normal sinus rhythm, rate 80, QTC 408.  Azithromycin and Rocephin initiated in ED, Decadron 6 mg IV given.  2/5/22: 75-year-old gentleman presented to the emergency room with history of chest pain.  The patient was discharged from the hospital following management focal COVID just 3 days ago prior to admission.  Patient was noted to have troponin trending up, and hence treated for NSTEMI.  Patient to start on heparin drip.  He eventually underwent coronary angiogram with intervention and DES stent.  The patient's symptoms have resolved.  The patient has developed right groin hematoma on the site of catheterization, and as per my review, the hematoma is resolving and lower extremity pulses are within normal range.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Lung disorder, Oxygen saturation decreased, Pneumonia, Pulmonary mass, Pyrexia
Clinical narrative: Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) Pfizer Dose 3 8/20/21 (EW0177) COVID Positive 1/30/22  1/30/22: Patient is a 75-year-old male who is immunosuppressed status post right renal transplant (2020) secondary to polycystic kidney disease who presented to ED with complaints of shortness of breath.  Patient has been fully vaccinated against COVID-19 and received his booster. He also tested positive for COVID last October.  Patient recently traveled with his wife who has since tested positive for COVID.  Patient began developing sinus congestion, low-grade fevers and loss of taste and smell. He was tested for COVID on Monday of last week with positive results.  He has been monitoring his pulse ox at home for the past several days and it has been dropping below 90%. He began experiencing shortness of breath yesterday with worsening symptoms today. He denies chest pain. No nausea, vomiting or diarrhea.  He has a past medical history of hypertension, GERD, hyperlipidemia, obstructive sleep apnea and prediabetes.  Patient follows with medical facility for renal transplant and is an on mycophenolate mofetil, prednisone and tacrolimus.  Patient did receive monoclonal antibody infusion 2 days ago.   On arrival to ED patient was hypoxic on room air at 87%, supplemental oxygen was applied any is currently on 4 L saturating around 94%.  Laboratory findings were significant for CKD stage 4 BUN 28 and creatinine 1.34. Hypomagnesemia 1.5.  Given 1 g Mag rider in ED.  D-dimer 0.61.  C reactive 3.60.  Chest x-ray shows new severe airspace disease in both lungs consistent with pneumonia. Unchanged right lower lobe nodule most consistent with granuloma.  EKG normal sinus rhythm, rate 80, QTC 408.  Azithromycin and Rocephin initiated in ED, Decadron 6 mg IV given.  2/5/22: 75-year-old gentleman presented to the emergency room with history of chest pain.  The patient was discharged from the hospital following management focal COVID just 3 days ago prior to admission.  Patient was noted to have troponin trending up, and hence treated for NSTEMI.  Patient to start on heparin drip.  He eventually underwent coronary angiogram with intervention and DES stent.  The patient's symptoms have resolved.  The patient has developed right groin hematoma on the site of catheterization, and as per my review, the hematoma is resolving and lower extremity pulses are within normal range.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinus congestion, Troponin increased
Clinical narrative: Pfizer Dose 1 3/3/21 (EN6204) Pfizer Dose 2 3/24/21 (EP6955) Pfizer Dose 3 8/20/21 (EW0177) COVID Positive 1/30/22  1/30/22: Patient is a 75-year-old male who is immunosuppressed status post right renal transplant (2020) secondary to polycystic kidney disease who presented to ED with complaints of shortness of breath.  Patient has been fully vaccinated against COVID-19 and received his booster. He also tested positive for COVID last October.  Patient recently traveled with his wife who has since tested positive for COVID.  Patient began developing sinus congestion, low-grade fevers and loss of taste and smell. He was tested for COVID on Monday of last week with positive results.  He has been monitoring his pulse ox at home for the past several days and it has been dropping below 90%. He began experiencing shortness of breath yesterday with worsening symptoms today. He denies chest pain. No nausea, vomiting or diarrhea.  He has a past medical history of hypertension, GERD, hyperlipidemia, obstructive sleep apnea and prediabetes.  Patient follows with medical facility for renal transplant and is an on mycophenolate mofetil, prednisone and tacrolimus.  Patient did receive monoclonal antibody infusion 2 days ago.   On arrival to ED patient was hypoxic on room air at 87%, supplemental oxygen was applied any is currently on 4 L saturating around 94%.  Laboratory findings were significant for CKD stage 4 BUN 28 and creatinine 1.34. Hypomagnesemia 1.5.  Given 1 g Mag rider in ED.  D-dimer 0.61.  C reactive 3.60.  Chest x-ray shows new severe airspace disease in both lungs consistent with pneumonia. Unchanged right lower lobe nodule most consistent with granuloma.  EKG normal sinus rhythm, rate 80, QTC 408.  Azithromycin and Rocephin initiated in ED, Decadron 6 mg IV given.  2/5/22: 75-year-old gentleman presented to the emergency room with history of chest pain.  The patient was discharged from the hospital following management focal COVID just 3 days ago prior to admission.  Patient was noted to have troponin trending up, and hence treated for NSTEMI.  Patient to start on heparin drip.  He eventually underwent coronary angiogram with intervention and DES stent.  The patient's symptoms have resolved.  The patient has developed right groin hematoma on the site of catheterization, and as per my review, the hematoma is resolving and lower extremity pulses are within normal range.
Age: 73.0
Sex: F
Vaccine: PNC20
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Skin warm
Clinical narrative: pt had sore arm for a couple of days then 5 days after injection her arm became red, swollen, warm to touch.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Nausea, Slow speech
Clinical narrative: I gave patient second dose of Moderna vaccination about 6:35pm on 6/29/222022.  She came back about 5 minutes later and said she felt dizzy and nauseous.  I had her sit down for 30 minutes.  She got better then started to get worse.  She said her face felt wierd or numb.  She asked if her speech sounded slow.  I then hold her I am going to call 911 for an ambulance to come check her out.  The ambulance came and took her to the hospital.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site rash
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Systemic: RASH AT INJECTION SITE - GETTING LARGER-Medium
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Lower respiratory tract congestion
Clinical narrative: I started getting symptoms of fatigue, chest congestion, and difficult cough. I also had headaches as well. I did have leg pains like a Charlie horse which is leg cramps. I had a low grade fever. On 6/20/2022 I took a COVID-19 test that was negative. On 6/21/2022 I took another COVID-19 test which was positive. I called my doctor and was scheduled a PCR test that was positive. I had a telehealth visit after was scheduled an antibody infusion. On 6/23/2022, I had the antibody infusion which I feel that helped with my symptoms. My symptoms lasted for about 7 days. I still have lingering symptoms of cough and minor sinus congestion as well as the leg cramps.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms, Pain in extremity, Pyrexia, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: I started getting symptoms of fatigue, chest congestion, and difficult cough. I also had headaches as well. I did have leg pains like a Charlie horse which is leg cramps. I had a low grade fever. On 6/20/2022 I took a COVID-19 test that was negative. On 6/21/2022 I took another COVID-19 test which was positive. I called my doctor and was scheduled a PCR test that was positive. I had a telehealth visit after was scheduled an antibody infusion. On 6/23/2022, I had the antibody infusion which I feel that helped with my symptoms. My symptoms lasted for about 7 days. I still have lingering symptoms of cough and minor sinus congestion as well as the leg cramps.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Peripheral swelling, Product administered at inappropriate site, Skin reaction, Skin warm
Clinical narrative: per patient, next day had huge red swollen area on arm, that was red, swollen and hot to touch. She also had a migraine in the back of the head that only went away when she laid down
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive
Clinical narrative: Patient was a resident of a Healthcare, with a hx of insulin-dependent diabetes, stable hypertension, hypothyroidism, dyslipidemia.  Patient tested positive for Covid-19 at NHC on 11/12/2021.  Patient was not hospitalized for this, and expired at the facility on 12/29/2021.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash macular, Urticaria
Clinical narrative: Shot was at 11am 6/25/22, and nothing noted at bed time, but by 8am a large red hive was noticed on his chest.  It was a light read with splotchy edges.  It extended over the sternum and over to the right nipple.  My son did not report any pain, ache or pain.  He had no fever and no other symptoms.  The red intensity increased over the day but began to diminish by evening. It was nearly 100% gone 24 hours later.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Oropharyngeal pain, Pyrexia
Clinical narrative: I had a sore throat, cough low grade fever,  I took a home COVID-19 test that came back positive. I called my doctor who called in a prescription of Paxlovid. I felt good after a few days. Then I had rebound symptoms and the fatigue had increased more than before. I went in to see my doctor for a follow up visit from a surgery and I still felt the fatigue. My doctor feels that I am on the mend.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a sore throat, cough low grade fever,  I took a home COVID-19 test that came back positive. I called my doctor who called in a prescription of Paxlovid. I felt good after a few days. Then I had rebound symptoms and the fatigue had increased more than before. I went in to see my doctor for a follow up visit from a surgery and I still felt the fatigue. My doctor feels that I am on the mend.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Malaise, SARS-CoV-2 test positive
Clinical narrative: First COVID symptoms appeared May 18 tested negative  Tested Positive May 20 twice with two different home testing kits and scheduled a telehealth  visit with my internet. Paxlovid was prescribed and begun on the 20th, symptoms of cough and fatigue subsided by the 24th and by the 26 symptoms were essentially gone with only an occasional cough.  No recurrence as of today 6/30/22.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test normal, Chest X-ray normal, Dizziness, Magnetic resonance imaging normal, Sleep disorder
Clinical narrative: Starting the night of receiving the vaccine,  I would have these episodes where I wake up numerous times a night and when I would move around I would have vertigo. Sometimes it would happen numerous times a night and other nights it would not happen at all. It would happen for about 3-5 days then would go away. Then, it re-started on 06/12/2022 where it was all day and happened about 8 times that day. This time, it happened if I looked down and I would feel dizzy and light headed. I went into the emergency room and they did blood work, a chest x ray, MRI and a few other tests. They ruled out a bunch of stuff and determined it was vertigo, and referred me to an ENT. I saw them and they ruled out everything and I was referred to see a neurologist and an ear specialist. I am waiting to make an appointment. By 06 /15/2022, I was mostly back to normal and I have not had an episode since then.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccine positive rechallenge, Vertigo
Clinical narrative: Starting the night of receiving the vaccine,  I would have these episodes where I wake up numerous times a night and when I would move around I would have vertigo. Sometimes it would happen numerous times a night and other nights it would not happen at all. It would happen for about 3-5 days then would go away. Then, it re-started on 06/12/2022 where it was all day and happened about 8 times that day. This time, it happened if I looked down and I would feel dizzy and light headed. I went into the emergency room and they did blood work, a chest x ray, MRI and a few other tests. They ruled out a bunch of stuff and determined it was vertigo, and referred me to an ENT. I saw them and they ruled out everything and I was referred to see a neurologist and an ear specialist. I am waiting to make an appointment. By 06 /15/2022, I was mostly back to normal and I have not had an episode since then.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Abdominal pain, Adnexal torsion, Cholelithiasis, Musculoskeletal chest pain, Ovarian operation
Clinical narrative: 10 days after getting my 3rd dose (booster) of the vaccine I ended up in the ER in excruciating abdominal pain.   I was having crippling pain on the right side of the abdomen (lower pelvic area and upper under ribs).   I was given 2 ultrasounds.  The trans-vaginal ultrasound revealed I have an ovarian torsion that required emergency surgery.  I was transported to another hospital immediately to have the surgery.   The ER had also done an ultra-sound of my gallbladder and found gallstones.  I had another surgery to have those removed on 1/19/22.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain, Pelvic pain, Ultrasound biliary tract abnormal, Ultrasound scan vagina abnormal
Clinical narrative: 10 days after getting my 3rd dose (booster) of the vaccine I ended up in the ER in excruciating abdominal pain.   I was having crippling pain on the right side of the abdomen (lower pelvic area and upper under ribs).   I was given 2 ultrasounds.  The trans-vaginal ultrasound revealed I have an ovarian torsion that required emergency surgery.  I was transported to another hospital immediately to have the surgery.   The ER had also done an ultra-sound of my gallbladder and found gallstones.  I had another surgery to have those removed on 1/19/22.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Malaise, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: I did not have a reaction to the vaccine. I started to feel COVID-19 symptoms on 6/21/22 which was nasal congestion and I did the at home COVID-19 test and it was positive. We where out-of-state at the time I was feeling sick. I had a telehealth visit with a provider on 6/23/22. I was given a prescription for PAXLOVID. As of today, I still have a little congestion.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Aortic aneurysm, Back pain, COVID-19, Chest pain, Computerised tomogram thorax abnormal
Clinical narrative: Patient presented to Hospital on 06/03/2022 with worsening chest and back pain.  CT scan showed a significant enlargement of her descending aorta and several ulcers with concerning hematomas around the aorta.  Patient recently tested positive for Covid-19 on 05/27/2022.  Patient was admitted to hospital services and refused any intervention, knowing that the aneurysm may rupture and lead to death.  Patient requested palliative care and passed on 06/06/2022.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Haematoma, Refusal of treatment by patient, SARS-CoV-2 test positive, Ulcer
Clinical narrative: Patient presented to Hospital on 06/03/2022 with worsening chest and back pain.  CT scan showed a significant enlargement of her descending aorta and several ulcers with concerning hematomas around the aorta.  Patient recently tested positive for Covid-19 on 05/27/2022.  Patient was admitted to hospital services and refused any intervention, knowing that the aneurysm may rupture and lead to death.  Patient requested palliative care and passed on 06/06/2022.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: PATIENT RECIEVED BOOSTER DOSE 2 MONTHS 2 EARLY AND IS NOT CLEARY INDICATED TO HAVE RECIEVED THE VACCINE AS DOES NOT MEET IMMUNOCOMPROMISED STATUS. WAS GIVEN VACCINE EARLY DUE TO ERROR THAT LED TO VACCINE NOT BEING DOCUMENTED PROPERLY.  PATIENT DID NOT EXPIERENCE ANY ADVERSE EFFECTS FROM THE EARLY BOOSTER.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: PATIENT RECIEVED BOOSTER DOSE 2 MONTHS 2 EARLY AND IS NOT CLEARY INDICATED TO HAVE RECIEVED THE VACCINE AS DOES NOT MEET IMMUNOCOMPROMISED STATUS. WAS GIVEN VACCINE EARLY DUE TO ERROR THAT LED TO VACCINE NOT BEING DOCUMENTED PROPERLY.  PATIENT DID NOT EXPIERENCE ANY ADVERSE EFFECTS FROM THE EARLY BOOSTER.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Feeling abnormal, SARS-CoV-2 test positive
Clinical narrative: I had a little cough that I did not think much of because I have asthma. I went out of town on the 9th and I still had the cough. The next day I was feeling out of breath and out of sorts. The next morning on the 11th, I still wasn't feeling right so we decided to take the home COVID-19 which was positive. We came and called my doctor and she prescribed PAXLOVID. I took the first dose that evening. My symptoms were mild. I never had a fever. I can't say that the PAXLOVID helped since I really was not that sick. My symptoms did not get worse though. I do still have a slight cough but it could be seasonal allergies.
Age: 56.0
Sex: M
Vaccine: TDAP, VARZOS
Symptoms: Wrong product administered
Clinical narrative: Yesterday MA had a patient come in for his second Shingrix vaccine.  In his chart, the Private log for vaccines in the lab, and his receipt for the vaccine, MA wrote down and marked "Shingrix" everywhere. However, when MA went to get the vaccine ready, MA grabbed a Tdap vaccine and administered that to him instead of the Shingrix. Peer check and she as well, did not catch the wrong vaccine.  The tdap vaccine was also not from our private batch of vaccines, it  came from the 317 batch.  Said the tdap was fine for him to have in the end, and we did call the patient and i left a voicemail for him to return our call but i have not heard back from him. I did try calling agian this morning with no answer.   Patient came in today to receive shingrix vaccine on 6/30/22
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Headache, Influenza like illness
Clinical narrative: I tested positive for Covid-19 on 6/16/22 with fever, cough, headache, chest and head congestion, flu like symptoms fatigue
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: I tested positive for Covid-19 on 6/16/22 with fever, cough, headache, chest and head congestion, flu like symptoms fatigue
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received expired medication. confirmed with manufacturer that dose maintained its efficacy. No follow-up needed. no adverse outcome.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Incorrect dose was administered. 0.5 ml was administered.  Correct dose is 0.25 ml.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasal congestion, Pain, Pyrexia
Clinical narrative: The symptoms were quite long lasting. Chest congestion, nasal congestion, sneezing and cough, 101 degree fever, body aches. I'm going on my 5th day.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive, Sneezing
Clinical narrative: The symptoms were quite long lasting. Chest congestion, nasal congestion, sneezing and cough, 101 degree fever, body aches. I'm going on my 5th day.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Discomfort, Dyspnoea, Dyspnoea exertional
Clinical narrative: Pfizer Dose 1 3/11/21 (EN6205) Pfizer Dose 2 4/2/21 (ER8734) COVID Positive 2/5/21  2/5/22: 75-year-old gentleman presented to the emergency room with complaint of increasing shortness of breath for the past 2 days. Patient drove himself to the emergency room.  He reports increased shortness of breath with activities.  He denies chest pain.  Denies fever.  In the emergency room, he was noted to be desaturating into the 80s, and he was placed on up to 15 L oxygen via non-rebreather mask. Currently, patient is saturating 96% on room air.  He seems comfortable.  The patient reports that he was vaccinated for COVID-19 virus 2 times.  He denies abdominal discomfort.  2/7/22: 75-year-old gentleman presented to the emergency room with a history of a fever and increased shortness of breath with activity as well as sore throat.  The patient was noted to be hypoxic, 83% on room air. He was put on about 15 L of oxygen via mask.  Further evaluation was suggestive of COVID-19 pneumonia with hypoxia.  The patient was started on remdesivir, dexamethasone as well as empiric antibiotic therapy.  The patient's condition progressively improved.  His oxygen requirement kept decreasing from 15 to 10, 8, 6, 4, 2, 1 L/min oxygen via nasal cannula. Patient has been taken off oxygen, ambulating with less discomfort.